Convert your VK2735 dose
Vial
Result
Converted amount2,500 mcg
Dose mass2,500 mcg
Concentration2,500 mcg/mL
Draw volume1 mL
U-100 syringe100 units
Reported study ranges
| Purpose | Route | Reported range | Frequency |
|---|---|---|---|
| obesity treatment (subcutaneous formulation — clinical trial dosing) | subcutaneous | 2.5–15 mg | once weekly |
| obesity treatment (oral formulation — clinical trial dosing) | oral | 25–100 mg | once daily |
Ranges are reported from the literature for research context only. They are not a protocol and not a recommendation.
Concentration by vial and diluent
| Vial | 1 mL diluent | 2 mL diluent | 3 mL diluent |
|---|---|---|---|
| 2 mg | 2,000 mcg/mL | 1,000 mcg/mL | 667 mcg/mL |
| 5 mg | 5,000 mcg/mL | 2,500 mcg/mL | 1,667 mcg/mL |
| 10 mg | 10,000 mcg/mL | 5,000 mcg/mL | 3,333 mcg/mL |
Concentration is vial mass divided by diluent volume. Reconstitution volume changes what you draw, never the dose itself.
What to draw for 2,500 mcg
| Vial | Diluent | Draw volume | U-100 units | Doses per vial |
|---|---|---|---|---|
| 2 mg | 1 mL | 1.25 mL | 125 units | 1 |
| 2 mg | 2 mL | 2.5 mL | 250 units | 1 |
| 2 mg | 3 mL | 3.75 mL | 375 units | 1 |
| 5 mg | 1 mL | 0.5 mL | 50 units | 2 |
| 5 mg | 2 mL | 1 mL | 100 units | 2 |
| 5 mg | 3 mL | 1.5 mL | 150 units | 2 |
| 10 mg | 1 mL | 0.25 mL | 25 units | 4 |
| 10 mg | 2 mL | 0.5 mL | 50 units | 4 |
| 10 mg | 3 mL | 0.75 mL | 75 units | 4 |
Calculated for the low end of the reported obesity treatment (subcutaneous formulation — clinical trial dosing) range. Change the dose in the calculator above for any other amount.
VK2735 at a glance
~7 days (estimated, subcutaneous formulation based on once-weekly dosing kinetics)
Half-life
Not established
Molecular weight — molar conversion unavailable
subcutaneous, oral
Routes
research only
Legal status